Tetrous

Series-A
tetrous.com Biotech & Healthcare Sherman Oaks, United States
Total Funding $6.5M
Latest Round $6.5M Series-A
Last Announced Mar 25, 2025
Investors Undisclosed
Decision Makers 3 Verified

About Tetrous

Biologic solutions to optimize enthesis reformation, EnFix® is the future of bone to tendon healing.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Sherman Oaks, United States
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website tetrous.com
Domain Registered Date Oct 3, 2018

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $6,500,000 · Series-A

    startupintros.com

  2. Milestone

    Website domain registered

    tetrous.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Tetrous.

Funding History

1 Round
Series-A · Mar 25, 2025

Founders & Leadership

3

Andrew J. Carter

Founder

Work email & phone locked Unlock →

Bradley E. Patt

Co-founder, CEO, and Chairman of the Board

Work email & phone locked Unlock →

Thurman Ballard

Vice President of Sales

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts